COVID-19 blood research

COVID-19 Research at Key Bio: Convalesced Patients – Plasma & Immune Cells

Recovered patients carrying SARS-CoV-2 antibodies are being collected under Key Biologics newest IRB-Approved protocol to help drive therapeutic agent & vaccine development. Responding to the FDA’s call-to-action for convalesced plasma & other blood products collection, and to meet mounting requests from institutional & biopharmaceutical researchers in need of premium cells, Key Bio’s COVID-19 protocol is active in…

T Cells

Multiple Myeloma Patient Blood Cell Donors Drive New Therapy Progress

MMRF Funds Critical Research Relying on Patients Multiple Myeloma Research Foundation + NexImmune Partnership MMRF’s mission to advance new multiple myeloma therapy into clinical trials for MM patients includes a new formal partnership with NexImmune. A world leader in cancer research, the MMRF’s investment will advance NexImmune’s promising immuno oncology drug candidate NEXI-002 and support…

blood donors

Blood Stem Cells & WBCs Depleted by Disease? Donors to the Rescue

Blood Stem Cells Power Supply Blood stem cells produce billions of new blood cells daily, providing the 3 blood cell types that sustain human life: Oxygen-carrying red blood cells, Clot-forming platelets that stop bleeding, Disease-fighting white blood cells Without constant new blood cell production, survival is threatened. Blood Stem Cells Only Make More Blood Cells…

Cells in Motion: Recent Research Using Astarte Cells

Our customers have recently published some exciting research in leading publications. Check out the latest 2019 research featuring our immune cells and products.   Effect of comedications and endotoxins on mesenchymal stem cell secretomes, migratory and immunomodulatory capacity Durand et al. examine the effect of immunosuppressive drugs and lipopolysaccharides/endotoxins on the secretory profile, migration towards…